Multinational Corporation Eli Lilly Lobbied For Obamacare, Now Against It

Photo Credit: Charles DharapakEli Lilly CEO John Lechleiter, who previously lobbied on behalf of Obamacare, said that one of President Obama’s costly new health-care reforms would have “catastrophic” consequences for innovation and that he plans to fight against it.

Lechleiter condemned Obama’s “dual eligibles” rebate plan at the annual Eli Lilly shareholder meeting Monday in Indianapolis.

“He said it would have fairly catastrophic consequences to the industry,” Eli Lilly spokesman Greg Kueterman told The Daily Caller.

Eli Lilly is a major drug maker and the world’s largest manufacturer of psychiatric medications.

Read more from this story HERE.